title: Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients.
abstract: BACKGROUND
  N-acetylaspartate (NAA) in the medial temporal lobe (MTL) and parietal lobe gray matter (GM) is diminished in Alzheimer disease (AD). Because NAA is considered a marker of neuronal integrity, reduced medial temporal and parietal lobe NAA could be an early indication of dementia-related pathology in elderly individuals.
  
  
  OBJECTIVE
  1) To determine whether cognitively impaired but nondemented (CIND) elderly individuals exhibit a similar pattern of reduced medial temporal and parietal lobe NAA as AD patients. 2) To compare regional NAA patterns, hippocampal and neocortical gray matter (GM) volumes in CIND patients who remained cognitively stable and those who became demented over 3.6 years of follow-up. 3) To examine the relationship between memory performance, medial temporal lobe NAA, and hippocampal volume.
  
  
  METHODS
  Seventeen CIND, 24 AD, and 24 cognitively normal subjects were studied using MRSI and MRI.
  
  
  RESULTS
  Relative to controls, CIND patients had reduced MTL NAA (19 to 21%, p = 0.005), hippocampal (11 to 14%, p < or = 0.04), and neocortical GM (5%, p = 0.05) volumes. CIND patients who later became demented had less MTL NAA (26%, p = 0.01), hippocampal (17 to 23%, p < or = 0.05), and neocortical GM (13%, p = 0.02) volumes than controls, but there were no significant differences between stable CIND patients and controls. MTL NAA in combination with hippocampal volume improved discrimination of CIND and controls over hippocampal volume alone. In AD and CIND patients, decreased MTL NAA correlated significantly with impaired memory performance.
  
  
  CONCLUSIONS
  Reduced medial temporal lobe N-acetylaspartate, together with reduced hippocampal and neocortical gray matter volumes, may be early indications of dementia-related pathology in subjects at high risk for developing dementia.
authors.affiliation: Magnetic Resonance Unit, San Francisco Veterans Affairs Medical Center, 4150 Clement Street, 116R, San Francisco, CA 94121, USA. llchao@itsa.ucsf.edu
authors.forename: L L
authors.initials: LL
authors.lastname: Chao
authors.forename: N
authors.initials: N
authors.lastname: Schuff
authors.forename: J H
authors.initials: JH
authors.lastname: Kramer
authors.forename: A T
authors.initials: AT
authors.lastname: Du
authors.forename: A A
authors.initials: AA
authors.lastname: Capizzano
authors.forename: J
authors.initials: J
authors.lastname: O'Neill
authors.forename: O M
authors.initials: OM
authors.lastname: Wolkowitz
authors.forename: W J
authors.initials: WJ
authors.lastname: Jagust
authors.forename: H C
authors.initials: HC
authors.lastname: Chui
authors.forename: B L
authors.initials: BL
authors.lastname: Miller
authors.forename: K
authors.initials: K
authors.lastname: Yaffe
authors.forename: M W
authors.initials: MW
authors.lastname: Weiner
mesh_terms: D000368:Aged; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000032:analysis; D001284:Atrophy; D003072:Cognition Disorders / Q000378:metabolism* / Q000473:pathology; D003704:Dementia / Q000453:epidemiology; D005260:Female; D006624:Hippocampus / Q000737:chemistry / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D010296:Parietal Lobe / Q000378:metabolism / Q000473:pathology; D012307:Risk Factors; D013702:Temporal Lobe / Q000737:chemistry* / Q000473:pathology
chemical_list: D001224:Aspartic Acid; C000179:N-acetylaspartate